Keyphrases
Clinical Trials
100%
Trial Results
100%
Non-response
100%
Efficacy Data
100%
Psoriasis Therapy
100%
Imputation Methods
66%
Response Rate
50%
Secukinumab
50%
Multiple Imputation
33%
Missing Data
33%
Last Observation Carried Forward
33%
Conservative Methods
33%
Trial Data
16%
Methodological Challenges
16%
Severity Index
16%
Psoriasis
16%
Psoriasis Area
16%
Area Index
16%
Psoriasis Severity
16%
Moderate-to-severe Psoriasis
16%
Randomized Double-blind Trial
16%
2-phase
16%
Data Imputation
16%
Long-term Clinical Study
16%
Mg-based Materials
16%
Medicine and Dentistry
Clinical Trial
100%
Psoriasis
100%
Secukinumab
100%
Clinician
33%
Biological Product
33%
Post-Hoc Analysis
33%
Awareness
33%
Psoriasis Vulgaris
33%
Psoriasis Area and Severity Index
33%
Mathematics
Trial Result
100%
Nonresponse
100%
Imputation Method
66%
Response Rate
50%
Multiple Imputation
33%
Observed Data
33%
Data Imputation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Psoriasis
100%
Secukinumab
100%
Biological Product
33%
Psoriasis Vulgaris
33%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Secukinumab
100%
Awareness
33%